Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.7M Buy
+74,460
New +$31.3M 0.04% 595
2025
Q2
Sell
-128,684
Closed -$79.2M 2229
2025
Q1
$79.2M Buy
128,684
+25,652
+25% +$14.6M 0.18% 133
2024
Q4
$54.6M Buy
+103,032
New +$58.1M 0.12% 198
2023
Q2
Sell
-9
Closed -$4.84K 2235
2023
Q1
$4.84K Buy
+9
New +$4.59K ﹤0.01% 2082
2021
Q3
Sell
-31,600
Closed -$15M 1059
2021
Q2
$15M Buy
+31,600
New +$15.2M 0.07% 353
2021
Q1
Sell
-20,500
Closed -$10.9M 985
2020
Q4
$10.9M Buy
20,500
+15,500
+310% +$7.62M 0.05% 424
2020
Q3
$2.4M Sell
5,000
-21,900
-81% -$10.7M 0.01% 682
2020
Q2
$12.1M Buy
+26,900
New +$12M 0.08% 291
2020
Q1
Sell
-436
Closed -$192K 806
2019
Q4
$192K Sell
436
-400
-48% -$168K ﹤0.01% 850
2019
Q3
$349K Sell
836
-80,600
-99% -$32.9M ﹤0.01% 825
2019
Q2
$29.4M Sell
81,436
-21,700
-21% -$7.25M 0.15% 173
2019
Q1
$33M Buy
103,136
+22,936
+29% +$7.04M 0.15% 170
2018
Q4
$22.7M Sell
80,200
-5,900
-7% -$1.78M 0.11% 233
2018
Q3
$27.5M Buy
86,100
+9,700
+13% +$3.09M 0.11% 231
2018
Q2
$24.6M Buy
+76,400
New +$23.9M 0.1% 251

Other funds holding CHE

Steven Cohen's CHE Position: Q2 2026 in Review

Steven Cohen opened a new position in Chemed (CHE) in Q2 2026: 74,460 shares worth $34.7M. The stake represents 0.04% of the portfolio and ranks #595 among its holdings. This is a return to the name: Steven Cohen previously reported a position in CHE as recently as Q1 2025.

Steven Cohen first reported a position in CHE in Q2 2018 and has held it in 15 quarters since. The position peaked at $79.2M in Q1 2025. 528 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Steven Cohen held 74,460 shares of Chemed worth $34.7M as of Q2 2026.
  • Chemed was a new Steven Cohen position in Q2 2026.
  • Chemed made up 0.04% of Steven Cohen's portfolio in Q2 2026, its #595 holding.
  • Steven Cohen first reported a position in Chemed in Q2 2018 and has held it in 15 quarters since.
  • Steven Cohen's Chemed position peaked at $79.2M in Q1 2025.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.